Antiviral treatment for Bell's palsy (idiopathic facial paralysis)
- PMID: 26559436
- DOI: 10.1002/14651858.CD001869.pub8
Antiviral treatment for Bell's palsy (idiopathic facial paralysis)
Abstract
Background: Corticosteroids are widely used in the treatment of idiopathic facial paralysis (Bell's palsy), but the effectiveness of additional treatment with an antiviral agent is uncertain. Significant morbidity can be associated with severe cases of Bell's palsy. This review was first published in 2001 and revised several times, most recently in 2009. This version replaces an update of the review in Issue 7 of the Cochrane Library subsequently withdrawn because of an ongoing investigation into the reliability of data from an included study.
Objectives: To assess the effects of antiviral treatments alone or in combination with any other therapy for Bell's palsy.
Search methods: On 7 October 2014 we searched the Cochrane Neuromuscular Disease Group Specialized Register, CENTRAL, MEDLINE, EMBASE, LILACS, DARE, NHS EED, and HTA. We also reviewed the bibliographies of the identified trials and contacted trial authors and known experts in the field and relevant drug companies to identify additional published or unpublished data. We searched clinical trials registries for ongoing studies.
Selection criteria: We considered randomised controlled trials or quasi-randomised controlled trials of antivirals with and without corticosteroids versus control therapies for the treatment of Bell's palsy. We excluded trials that had a high risk of bias in several domains.
Data collection and analysis: Pairs of authors independently assessed trials for relevance, eligibility, and risk of bias, using standard Cochrane procedures.
Main results: Ten trials, including 2280 participants, met the inclusion criteria and are included in the final analysis. Some of the trials were small, and a number were at high or unclear risk of bias. Other trials did not meet current best standards in allocation concealment and blinding. Incomplete recoveryWe found a significant benefit from adding antivirals to corticosteroids in comparison with corticosteroids alone for people with Bell's palsy (risk ratio (RR) 0.61, 95% confidence interval (CI) 0.39 to 0.97, n = 1315). For people with severe Bell's palsy (House-Brackmann scores of 5 and 6 or the equivalent in other scales), we found a reduction in the rate of incomplete recovery at month six when antivirals plus corticosteroids were used, compared to corticosteroids alone (RR 0.64, 95% CI 0.41 to 0.99, n = 478). The outcome for the participants receiving corticosteroids alone was significantly better than for those receiving antivirals alone (RR 2.82, 95% CI 1.09 to 7.32, n = 768). The treatment effect of placebo was significantly lower than that of antivirals plus corticosteroids (RR 0.56, 95% CI 0.41 to 0.76, n = 658). Antivirals alone produced no benefit compared with placebo (RR 1.10, 95% CI 0.87 to 1.40, n = 658). Motor synkinesis or crocodile tearsIn two trials comparing antivirals and corticosteroids with corticosteroids and placebo that assessed this outcome, we found a significant difference in long-term sequelae in favour of antivirals plus corticosteroids (RR 0.56, 95% CI 0.36 to 0.87, n = 469). Two trials comparing antivirals alone with corticosteroids alone investigating this outcome showed fewer sequelae with corticosteroids (RR 1.52, 95% CI 1.08 to 2.12, n = 472). We found no data on long-term sequelae for other comparisons. Adverse events Adverse event data were available in three studies giving comparison data on 1528 participants. None of the four comparisons (antivirals plus corticosteroids versus corticosteroids plus placebo or no treatment; antivirals versus corticosteroids; antivirals plus corticosteroids versus placebo; antivirals versus placebo) showed significant differences in adverse events between treatment and control arms. We could find no correlation with specific treatment within these results.
Authors' conclusions: Low-quality evidence from randomised controlled trials showed a benefit from the combination of antivirals with corticosteroids compared to corticosteroids alone for the treatment of Bell's palsy of various degrees of severity. Low-quality evidence showed a benefit of combination therapy compared with corticosteroids alone in severe Bell's palsy. Corticosteroids alone were more effective than antivirals alone and antivirals plus corticosteroids were more effective than placebo or no treatment. There was no benefit from antivirals alone over placebo.Moderate-quality evidence indicated that the combination of antivirals and corticosteroids reduced sequelae of Bell's palsy compared with corticosteroids alone.We found no significant increase in adverse events from the use of antivirals compared with either placebo or corticosteroids, based on low-quality evidence.
Update of
-
Antiviral treatment for Bell's palsy (idiopathic facial paralysis).Cochrane Database Syst Rev. 2015 Jul 1;(7):CD001869. doi: 10.1002/14651858.CD001869.pub6. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2015 Sep 07;(9):CD001869. doi: 10.1002/14651858.CD001869.pub7. Update in: Cochrane Database Syst Rev. 2015 Nov 09;(11):CD001869. doi: 10.1002/14651858.CD001869.pub8. PMID: 26130372 Updated.
Comment in
-
Antiviral treatment for Bell's palsy (idiopathic facial paralysis).Sao Paulo Med J. 2015 Jul-Aug;133(4):383. doi: 10.1590/1516-3180.20151334T1. Sao Paulo Med J. 2015. PMID: 26517150 Free PMC article.
-
Do Antiviral Medications Improve Symptoms in the Treatment of Bell's Palsy?Ann Emerg Med. 2017 Mar;69(3):364-365. doi: 10.1016/j.annemergmed.2016.05.026. Epub 2016 Jun 25. Ann Emerg Med. 2017. PMID: 27350020 No abstract available.
-
Antiviral Agents Added to Corticosteroids for Early Treatment of Adults With Acute Idiopathic Facial Nerve Paralysis (Bell Palsy).JAMA. 2016 Aug 23-30;316(8):874-5. doi: 10.1001/jama.2016.10160. JAMA. 2016. PMID: 27552621
Similar articles
-
Antiviral treatment for Bell's palsy (idiopathic facial paralysis).Cochrane Database Syst Rev. 2015 Jul 1;(7):CD001869. doi: 10.1002/14651858.CD001869.pub6. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2015 Sep 07;(9):CD001869. doi: 10.1002/14651858.CD001869.pub7. Update in: Cochrane Database Syst Rev. 2015 Nov 09;(11):CD001869. doi: 10.1002/14651858.CD001869.pub8. PMID: 26130372 Updated.
-
WITHDRAWN. Antiviral treatment for Bell's palsy (idiopathic facial paralysis).Cochrane Database Syst Rev. 2015 May 4;(5):CD001869. doi: 10.1002/14651858.CD001869.pub5. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2015 Jul 01;(7):CD001869. doi: 10.1002/14651858.CD001869.pub6. PMID: 25938618 Updated.
-
Antiviral treatment for Bell's palsy (idiopathic facial paralysis).Cochrane Database Syst Rev. 2009 Oct 7;(4):CD001869. doi: 10.1002/14651858.CD001869.pub4. Cochrane Database Syst Rev. 2009. Update in: Cochrane Database Syst Rev. 2015 May 04;(5):CD001869. doi: 10.1002/14651858.CD001869.pub5. PMID: 19821283 Updated.
-
WITHDRAWN: Aciclovir or valaciclovir for Bell's palsy (idiopathic facial paralysis).Cochrane Database Syst Rev. 2009 Apr 15;(2):CD001869. doi: 10.1002/14651858.CD001869.pub3. Cochrane Database Syst Rev. 2009. Update in: Cochrane Database Syst Rev. 2009 Oct 07;(4):CD001869. doi: 10.1002/14651858.CD001869.pub4. PMID: 19370569 Updated.
-
Physical therapy for Bell's palsy (idiopathic facial paralysis).Cochrane Database Syst Rev. 2011 Dec 7;(12):CD006283. doi: 10.1002/14651858.CD006283.pub3. Cochrane Database Syst Rev. 2011. PMID: 22161401
Cited by
-
Acute Peripheral Facial Palsy: Recent Guidelines and a Systematic Review of the Literature.J Korean Med Sci. 2020 Aug 3;35(30):e245. doi: 10.3346/jkms.2020.35.e245. J Korean Med Sci. 2020. PMID: 32743989 Free PMC article.
-
Update on Medical Management of Acute Peripheral Facial Palsy.J Audiol Otol. 2025 Jan;29(1):1-7. doi: 10.7874/jao.2024.00731. Epub 2025 Jan 20. J Audiol Otol. 2025. PMID: 39916394 Free PMC article. Review.
-
Comparison of acyclovir and famciclovir for the treatment of Bell's palsy.Eur Arch Otorhinolaryngol. 2016 Oct;273(10):3083-90. doi: 10.1007/s00405-016-3927-3. Epub 2016 Feb 12. Eur Arch Otorhinolaryngol. 2016. PMID: 26873601
-
New-onset Bell palsy and Lyme disease.Can Fam Physician. 2017 Dec;63(12):941. Can Fam Physician. 2017. PMID: 29237635 Free PMC article. No abstract available.
-
Infections in the differential diagnosis of Bell's palsy: a plea for performing CSF analysis.Infection. 2017 Apr;45(2):147-155. doi: 10.1007/s15010-016-0933-8. Epub 2016 Aug 16. Infection. 2017. PMID: 27530390
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous